Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

  • J Invest Dermatol. 2016 Jun;136(6):1302-1305. doi: 10.1016/j.jid.2015.12.047.
Charles Cassius  1 ,  Cécile Pages  2 ,  Jennifer Roux  2 ,  Raphael Lhote  2 ,  Romain Lavocat  3 ,  Delphine Réa  4 ,  Martine Bagot  2 ,  Samia Mourah  5 ,  Maxime Battistella  6 ,  Céleste Lebbé  7 ,  Nicolas Dumaz  5
Affiliations
  • 1. Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. Electronic address: [email protected].
  • 2. Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 3. Department of Plastic Surgery, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 4. Department of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 5. INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • 6. Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 7. Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
PMID: 26854489 DOI: 10.1016/j.jid.2015.12.047
Products